Tulika Tyagi

505 total citations
15 papers, 333 citations indexed

About

Tulika Tyagi is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tulika Tyagi has authored 15 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tulika Tyagi's work include CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and Arsenic contamination and mitigation (2 papers). Tulika Tyagi is often cited by papers focused on CAR-T cell therapy research (3 papers), Virus-based gene therapy research (2 papers) and Arsenic contamination and mitigation (2 papers). Tulika Tyagi collaborates with scholars based in United States, Australia and India. Tulika Tyagi's co-authors include Kamaleshwar P. Singh, Rashmi Sharma, Priyanka Sharma, Weimin Gao, Prathap Kumar S. Mahalingaiah, Sarah M. Larson, Satiro De Oliveira, Andy Tu, David Elashoff and WeiYu Lin and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Physiology-Cell Physiology.

In The Last Decade

Tulika Tyagi

15 papers receiving 328 citations

Peers

Tulika Tyagi

ONCOL

PFM

GENET

Jiang Shi-hu China

Ali Zekri Iran

Huei‐Sheng Huang Taiwan

Shotaro Yamano Japan

Iha Park South Korea

Chuanzhong Mei China

Chad Walesky United States

Xinhua Zhu China

Izumi Nakahara Japan

Jiang Shi-hu China

Tulika Tyagi

326 ×1.8

101 ×1.4

ONCOL

51 ×1.0

42 ×1.0

PFM

44 ×1.1

GENET

Citations per year, relative to Tulika Tyagi Tulika Tyagi (= 1×) peers Jiang Shi-hu

Countries citing papers authored by Tulika Tyagi

Since Specialization

Citations

This map shows the geographic impact of Tulika Tyagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tulika Tyagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tulika Tyagi more than expected).

Fields of papers citing papers by Tulika Tyagi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tulika Tyagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tulika Tyagi. The network helps show where Tulika Tyagi may publish in the future.

Co-authorship network of co-authors of Tulika Tyagi

This figure shows the co-authorship network connecting the top 25 collaborators of Tulika Tyagi. A scholar is included among the top collaborators of Tulika Tyagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tulika Tyagi. Tulika Tyagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lu, Cheng, Jack Bevers, Tulika Tyagi, et al.. (2024). AviTrap: A novel solution to achieve complete biotinylation. PLoS ONE. 19(4). e0297122–e0297122. 2 indexed citations

Richter, Joshua, Sheeba K. Thomas, Jacob P. Laubach, et al.. (2024). Cevostamab in Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study Demonstrate Clinically Meaningful Activity and Manageable Safety and Inform the Doses and Regimen for Combination Studies. Blood. 144(Supplement 1). 1021–1021. 8 indexed citations

Li, Maoyin, Xiaowei Sun, Erhu Lu, et al.. (2023). Novel Selective Quantification of Zinpentraxin Alfa Biotherapeutic in the Presence of Endogenous Isomer in Plasma Samples of Idiopathic Pulmonary Fibrosis Patients Using Immunoaffinity LC–MS. The AAPS Journal. 26(1). 9–9. 1 indexed citations

Tyagi, Tulika, et al.. (2023). Review of clinical applications and challenges with surface-guided radiation therapy. Journal of Cancer Research and Therapeutics. 19(5). 1160–1169. 1 indexed citations

Lin, WeiYu, Wei‐Ching Liang, Mauricio Maia, et al.. (2020). Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology. PLoS ONE. 15(12). e0244158–e0244158. 12 indexed citations

N’Diaye, Elsa-Noah, Ryan Cook, Hua Wang, et al.. (2020). Extracellular BMP1 is the major proteinase for COOH-terminal proteolysis of type I procollagen in lung fibroblasts. American Journal of Physiology-Cell Physiology. 320(2). C162–C174. 7 indexed citations

Larson, Sarah M., et al.. (2017). Pre-clinical development of gene modification of haematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy. Human Vaccines & Immunotherapeutics. 13(5). 1094–1104. 24 indexed citations

Tyagi, Tulika, et al.. (2015). Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2′-deoxycytidine in human breast cancer cells. Breast Cancer Research and Treatment. 149(3). 655–668. 32 indexed citations

Gschweng, Eric H., Sarah M. Larson, Andy Tu, et al.. (2014). Systematic Comparison of the EF-1 Alpha Short (EFS) and Viral Promoters for Gene Modification of Human Primary Cells for Clinical Applications. Blood. 124(21). 3497–3497. 1 indexed citations

10.

Tyagi, Tulika, Sarah M. Larson, Andy Tu, et al.. (2014). Second-Generation Chimeric Antigen Receptors Successfully Modify Hematopoietic Stem Cells for Immunotherapy of B-Lineage Malignancies. Blood. 124(21). 655–655. 1 indexed citations

11.

Tyagi, Tulika, et al.. (2013). Chronic exposure to arsenic, estrogen, and their combination causes increased growth and transformation in human prostate epithelial cells potentially by hypermethylation-mediated silencing of MLH1. The Prostate. 73(15). 1660–1672. 35 indexed citations

12.

Tyagi, Tulika, et al.. (2012). Effects of Chronic Exposure to Arsenic and Estrogen on Epigenetic Regulatory Genes Expression and Epigenetic Code in Human Prostate Epithelial Cells. PLoS ONE. 7(8). e43880–e43880. 29 indexed citations

13.

Tyagi, Tulika, et al.. (2011). VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future. Current Cancer Drug Targets. 11(5). 624–653. 76 indexed citations

14.

Singh, Kamaleshwar P., et al.. (2011). DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells. Cancer Letters. 316(1). 62–69. 55 indexed citations

15.

Sharma, Priyanka, Rashmi Sharma, & Tulika Tyagi. (2009). Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers. Current Pharmaceutical Design. 15(7). 758–776. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact